Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%.
Source link
Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Share:
nasdaqpicks.com
administrator
Related Posts
